Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine Cardioprotection in PCI
NCT01767987Phase 2Terminated
- Sponsor
- Harvey Hahn
- Start
- Nov 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ranolazine in Myocardial injury, sponsored by Harvey Hahn. Started Nov 2012; status: terminated.
02
Drugs
ranolazine
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on NCT01767987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01767987.